Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06059716 · ClinicalTrials.gov registry record · NA
Gluten Technology and Education for Celiac Health
A NA study of Celiac Disease, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 4
- Study locations
NCT06059716 is a NA study of Celiac Disease that is actively recruiting participants, run by Columbia University. The registered enrollment target is 200 participants, below the 1,972-participant average among 24 other Celiac Disease trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT06059716, a NA study of Celiac Disease, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 4
- Study locations
Study Summary
The investigators propose to plan for a multi-center randomized controlled trial (M-RCT) to test the effectiveness of novel gluten detection technologies as an adjunct to telemedicine to manage celiac disease in newly diagnosed adults. If successful, the proposed intervention will improve mucosal recovery, promote a shift in current practice of celiac disease management toward long-term monitoring, and represent a significant step toward reducing the severe physical and psychological consequences of celiac disease.
Conditions Studied
Interventions
- BEHAVIORAL Gluten detection technology
- BEHAVIORAL Continuous telemedicine monitoring
Study Locations (4)
Illinois
- University of Chicago Medical Center - Chicago
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
New York
- Columbia University Irving Medical Center - New York
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-10-08 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06059716
The ClinicalTrials.gov registry entry for NCT06059716 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,972-participant average among 24 other Celiac Disease trials with a reported enrollment target (90% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Celiac Disease appearing as the primary indexed condition, and to 2 interventions - of which Gluten detection technology is the first listed.
NCT06059716 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Illinois, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT06059716 about?
NCT06059716 is a clinical study titled "Gluten Technology and Education for Celiac Health". The investigators propose to plan for a multi-center randomized controlled trial (M-RCT) to test the effectiveness of novel gluten detection technologies as an adjunct to telemedicine to manage celiac disease in newly diagnosed adults. If successful, the proposed intervention will improve mucosal re...
What is the current status of trial NCT06059716?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-10-08. Estimated completion is 2028-08-31.
What conditions does trial NCT06059716 study?
This clinical trial studies the following conditions: Celiac Disease.
What interventions are being tested in trial NCT06059716?
The interventions under investigation include: Gluten detection technology (BEHAVIORAL), Continuous telemedicine monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT06059716?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06059716 being conducted?
This trial has 4 study locations across Illinois, Massachusetts, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Celiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tissue Destruction and Healing in Celiac Disease
RECRUITING · NA
-
Immune Responses to Gluten
RECRUITING · NA
-
T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge
COMPLETED · NA
-
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
COMPLETED · NA
-
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
COMPLETED · NA
-
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.